UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 6, 2014

BAXANO SURGICAL, INC.

(Exact name of registrant as specified in its charter)

Delaware

001-33744

33-0909022

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

110 Horizon Drive, Suite 230

Raleigh, North Carolina 27615

(Address of principal executive offices)

(Zip Code)

(919) 800-0020

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240. 13e-4(c))

Item 5.02

Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers

On November 6, 2014, Russell Hirsch, M.D., Ph.D., resigned as a member of the Board of Directors of Baxano Surgical, Inc. (the “Company”) and as a member of the Company’s Nominating and Corporate Governance Committee. Dr. Hirsch’s resignation was not a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

On November 7, 2014, Timothy Shannon resigned from his positions as Chief Financial Officer, Treasurer and Secretary of the Company.

On November 10, 2014, Roderick Young resigned as a member of the Board of Directors of the Company and as a member of the Company’s Audit Committee. Mr. Young’s resignation was not a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

SIGNATURE

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	BAXANO SURGICAL, INC.

Date: November 12, 2014	By:	/s/ Ken Reali
		Ken Reali
		President and Chief Executive Officer

BAXANO SURGICAL, INC. 8-K